Ketamine for Cancer and Pain Management plus our Free Webinar Series! - Journal Club

Episode Title: Ketamine for Cancer and Pain Management - Journal Club


Host: David Rosenblum, MD


Upcoming Free Webinars: 1. Exploring Innovative Mental Health Treatments which are well reimbursed    Discussing Spravato, Transmagnetic Stimulation, and Ketamine Infusion, sponsored by Big Leap Health. Register! (https://www.nrappain.org/pages/upcoming-pain-management-conferences)


(https://www.nrappain.org/pages/upcoming-pain-management-conferences)


2. Understanding Scrambler Therapy    Learn about this revolutionary approach to pain management. Register! (https://www.nrappain.org/pages/upcoming-pain-management-conferences)


3. Cervical Ultrasound: Anatomy and Interventional Pain Targets    Sponsored by Clarius, this session will explore advanced imaging techniques. Register! (https://clarius.com/webinar/precision-in-pain-management-ultrasound-guided-therapies-for-chronic-head-and-neck-pain/)


Sign up for the webinars and check out our full calendar of events. (https://www.nrappain.org/pages/upcoming-pain-management-conferences)


Join us for this insightful episode as we explore the potential of ketamine in transforming pain management practices!


Summary


In today's episode, we delve into the emerging role of ketamine in managing cancer and chronic pain. Our discussion is anchored around a comprehensive review article titled "Ketamine Use for Cancer and Chronic Pain Management," published in Frontiers in Pharmacology on February 1, 2021. This review, authored by Clayton Culp, Hee Kee Kim, and Salahadin Abdi, explores ketamine's potential as an analgesic in chronic pain conditions, particularly cancer-related neuropathic pain.


Key Points from the Review Article: - Mechanism of Action: Ketamine functions as an N-methyl-D-aspartate receptor antagonist, providing analgesic effects at sub-anesthetic doses. Its ability to counteract central nervous system sensitization makes it effective in opioid-induced hyperalgesia. - Clinical Efficacy: Recent studies highlight ketamine's potential to reduce pain scores and opioid consumption, offering a promising alternative for patients with refractory pain. - Safety Profile: At lower doses used for analgesia, ketamine's safety and adverse event profile are significantly improved compared to its use as an anesthetic. - Pharmacogenomics and Interactions: The article discusses how genetic variations can affect ketamine metabolism and highlights potential drug interactions that clinicians should be aware of.


Reference


Culp, Clayton, Hee Kee Kim, and Salahadin Abdi. "Ketamine use for cancer and chronic pain management." Frontiers in Pharmacology 11 (2021): 599721. (https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.599721/full)